New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export PBM’s income statement to Excel — free account
Psyence Biomedical Ltd.
PBM
2.97
0.11
+3.85%
After hours trading: 3.01, up 1.35%, last trade Fri 4:09pm Eastern.
Follow PBM
Alert me
Where the cash went Fiscal 2026, year to Mar 31, 2026
Free cash flow was −$8.1M: capital expenditures were more than operating cash flow. Cash rose by $1.3M. Lines the picture does not name came to +$14.0M. What is a cash flow statement?
- Free cash flow
- −$8.1M
- Returned to shareholders
- $0.00
- Debt, net
- $0.00 borrowed
- Change in cash
- +$1.3M over the period
| Operating cash flow | −8.1 |
|---|---|
| Free cash flow | −8.1 |
| Into investments, net | −4.5 |
| Other | +14.0 |
| Change in cash | 1.3 |
Free cash flow
| FY24 | FY25 | FY26 | |
|---|---|---|---|
| Operating cash flow | −$2.9M | −$3.7M | −$8.1M |
| Capex | $0 | $0 | $0 |
| Free cash flow | −$3M | −$3.7M | −$8.1M |
Figures in millions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '17 | Jan '21 | Jan '22 | Dec '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|
Net Income |
0.00 | 8.23 | 8.01 | 0.00 | (51.16) | 1.01 | (6.94) |
Depreciation & Amortization |
— | — | — | — | 0.00 | 0.00 | 0.01 |
Non Cash Items (Other) |
— | — | — | — | 49.39 | (4.36) | 0.00 |
Change in payables and accrued liability |
— | — | — | — | (1.04) | (0.36) | 0.01 |
Change in other assets and liabilities |
— | (0.57) | (0.40) | — | (0.14) | (0.03) | (1.23) |
Other operating activities |
0.00 | — | — | — | — | — | — |
Operating Cash Flow |
— | (0.84) | (0.52) | — | (2.95) | (3.73) | (8.14) |
Capital expenditures |
— | — | — | — | (0.01) | (0.01) | 0.00 |
Long-Term Investments Change (Net) |
— | — | — | — | — | — | (4.50) |
Other investing activities |
— | — | — | — | — | (0.01) | (0.01) |
Investing cash flow |
— | (255.00) | — | — | (0.01) | (0.02) | (4.51) |
Repayment/Issuance of Debt (Net) |
— | — | — | — | 2.35 | 1.00 | — |
Equity Repurchase (Common, Net) |
— | — | — | — | — | 1.74 | — |
Other financial activities |
— | (8.56) | (8.48) | — | — | 6.41 | 13.96 |
Financing cash flow |
— | 256.49 | — | — | 2.35 | 9.15 | 13.96 |
Change in Cash |
— | 0.65 | (0.52) | — | (0.60) | 5.40 | 1.31 |
Beginning Cash |
— | — | — | — | 1.33 | 0.73 | 6.14 |
Ending Cash |
— | — | — | — | 0.73 | 6.14 | 7.44 |
Stock Based Compensation |
— | — | — | — | 0.32 | — | 0.16 |
Dividends Paid (Common) |
0.00 | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
— | — | — | — | (1.17) | (0.39) | (1.22) |
Investments Change (Net) |
— | — | — | — | — | — | (4.50) |
Issuance/Purchase of Shares |
— | — | — | — | — | 1.74 | — |
In millions of $ except per-share values · columns are period end dates